20/20 Biolabs, Inc.
Current role
AIDX
Michael Lebowitz
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Lebowitz
The proxy statement of 20/20 Biolabs, Inc. reports total compensation of $151,600 for Michael Lebowitz in fiscal 2025, including a base salary of $89,600. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
20/20 Biolabs, Inc. (AIDX)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at 20/20 Biolabs, Inc.
Other people whose current roles at this company are on record from its filings.
- Jonathan Cohen CEO, Board Member
- John G. Compton Chairman
- Alan B. Bergman CFO
- Jiming Zhou COO
- John W. Rollins Board Member
- Michael A. Ross Board Member
- Prasanth Reddy Board Member
- Richard M. Cohen Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | 20/20 Biolabs, Inc. (AIDX) | Chief Scientific Officer | $89,600 | $151,600 |
| 2024 | 20/20 Biolabs, Inc. (AIDX) | Chief Scientific Officer | $76,800 | $270,353 |
Recent activity
No call appearances or filed executive changes recorded yet.